Catalogs >
Sartorius Group >
Treatment of Vivaspin® Concentrators

Treatment of Vivaspin® Concentrators
4Pages

Catalog excerpts

Treatment of Vivaspin® Concentrators - 1

Application Note November 05, 2020 Keywords or phrases: Ultrafiltration, passivation, protein concentration, low-concentration protein samples, protein yield, non-specific binding, adsorption Treatment of Vivaspin® Concentrators For Improved Recovery of Low-Concentrated Protein Samples Rik McRae¹,*, Claudia Naumann²,*, Kristin Hoehne, Robert Zeidler 1. Sartorius Stedim Lab Ltd, Sperryway, Stonehouse, Gloucestershire, GL10 3UT, UK 2. Sartorius Lab Instruments GmbH & Co. KG, Otto-Brenner-Straße 20, 37079 Göttingen, Germany * Correspondence E-Mail: adam.green@sartorius.com Abstract Ultrafiltration is a core technology for the concentration of molecules of interest in the laboratory and research setting. As molecule recovery is a key criteria for high performance; optimal membrane, MWCO and device handling must be in place. Further to this, certain techniques can be employed to minimize loss through non-specific adsorption to device housing material and membrane material. This is most important for samples with low starting concentrations in the nanogram to microgram range, where loss through adsorption can have a significant impact on end recoveries. Here we describe these “passivation” techniques that demonstrate increased recovery when used with low starting concentration samples. Find out more: www.sartorius.com/en/products/lab-filtration-purification/ultrafiltration-d

Open the catalog to page 1

Treatment of Vivaspin® Concentrators - 2

Introduction With appropriate device size and membrane cut-off selected, Vivaspin® products will typically yield recoveries for the concentrated sample > 90% when the starting sample contains over 0.1 mg/mL protein of interest. Depending on sample characteristics relative to the membrane type used, solute (protein) adsorption on the membrane surface is typically very low (2 – 10 µg/cm²) and in practice not detectable. This can increase to 20 – 100 µg/cm² when the filtrate is of interest and the sample must pass through the whole internal structure of the membrane. Whilst the relative...

Open the catalog to page 2

Treatment of Vivaspin® Concentrators - 3

Results and Discussion Passivation Procedure for Vivaspin® Ultrafiltration Concentrators A) Passivation Procedure 1. Wash the concentrators once by filling with Arium® water and spin the liquid through according to the respective protocol. 2. Remove residual water thoroughly by pipetting. Caution: Take care not to damage the membrane with the pipette tip. 3. Fill concentrators with the blocking solution of choice as given in Table 1. 4. Incubate the filled concentrators at room temperature for at least 2 hours (overnight is also possible except for Triton X-100 which is not recommended for...

Open the catalog to page 3

Treatment of Vivaspin® Concentrators - 4

Summary Passivation is an appropriate method to achieve increasing sample recovery when using very dilute samples. In addition to skimmed milk, other proteins (BSA), detergents and compounds are possible. However, it should be noted that this is a general procedure, not specific for any particular application. Depending on the hydrophilic | -phobic character of the protein non-specific binding may be more or less of a problem and the suggested passivation solutions may lead to different results. Even with the Hydrosart membrane, which is recommended for dilute samples, passivation of the...

Open the catalog to page 4

Treatment of Vivaspin® Concentrators 4Pages

Catalog excerpts

All Sartorius Group catalogs and technical brochures

Treatment of Vivaspin® Concentrators
4Pages